medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2021, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2021; 19 (1)

The Role of Dermatology During the covid-19 Pandemic in the Hospital de Especialidades Centro Médico Nacional Siglo XXI, IMSS

Tapia-Amador GB, Vázquez-Arroyo P, Pérez-Campos E, Varela-Pedraza D, Echeverría L, Lemini-López A, Anides-Fonseca A

Language: Spanish
References: 23
Page: 12-15
PDF size: 151.33 Kb.


ABSTRACT

The covid-19 pandemic has brought important changes to the medical profession. Not only those first-line medical specialties for covid-19 patients, but also dermatologists who are challenged treating new dermatological diseases. Dermatology has a fundamental role during this pandemic, since, it is the ideal medical specialty to treat all those individuals who have dermatological manifestations associated with general care, such as frequent hand washing and the use of personal protection equipment. An observational study on the staff of our hospital is reported, in order to help treat and/or prevent skin affections caused by the necessary protection that must be taken when facing the covid-19 pandemic.


REFERENCES

  1. Aarão TL, De Sousa JR, Falcão ASC, Falcão LFM y Quaresma JAS, Nerve growth factor and pathogenesis of leprosy: review and update, Frontiers in Immunology 2018; 9:1-8. https://doi.org/10.3389/fimmu. 2018.00939.

  2. Silva CAM y Belisle JT, Host lipid mediators in leprosy: the hypothesized contributions to pathogenesis, Frontiers in Immunology 2018; 9. https://doi.org/10.3389/fimmu.2018.00134.

  3. De Andrade KVF, Nery JS, Pescarini JM, Ramond A, De Souza TS et al., Geographic and socioeconomic factors associated with leprosy treatment default: an analysis from the 100 million Brazilian cohort, plos Neglected Tropical Diseases 2019; 13(9). https://doi.org/10.1371/journal. pntd.0007714.

  4. Pawar M y Zawar V, Mid-borderline leprosy masquerading as an overlap syndrome, Rheumatology 2018; 57(9):1686-88. https://doi. org/10.1093/rheumatology/key125.

  5. Pandhi D y Chhabra N, New insights in the pathogenesis of type 1 and type 2 lepra reaction, Indian J Dermatol Venereol Leprol 2013; 79:739-49.

  6. Oo YM, Páez A y Brown R, Leprosy: a rare case of infectious peripheral neuropathy in the United States, IDCases 2020; 20:e00765. https://doi.org/10.1016/j.idcr.2020.e00765.

  7. Fischer M, Leprosy: an overview of clinical features, diagnosis, and treatment, Journal of the German Society of Dermatology 2017; 15(8):801- 27. https://doi.org/10.1111/ddg.13301.

  8. Grzybowski A, Sak J, Suchodolska E y Virmond M, Lepra: various etiologies from miasma to bacteriology and genetics, Clinics in Dermatology 2015; 33(1):3-7. https://doi.org/10.1016/j.clindermatol.2014.07.012.

  9. World Health Organization, Global leprosy update 2015, Weekly Epidemiological Record, 2016; 91:405-20.

  10. Kaur G y Kaur J, Multifaceted role of lipids in Mycobacterium leprae, Future Microbiology 2017; 12(4):315-35. https://doi.org/10.2217/fmb- 2016-0173.

  11. Arenas R, Lepra. En Arenas R, Dermatología. Atlas, diagnóstico y tratamiento, 6ª ed., México, McGraw-Hill, 2015, pp. 406-20.

  12. Torres Guerrero E, Vargas Martínez F, Atoche Diéguez C, Arrazola J y Arenas Guzmán R, Lepra: clasificación y cuadro clínico, Dermatol Rev Mex 2012; 56(1):47-54.

  13. Peniche A. y Saúl A, Dermatosis bacterianas. En Saúl A, Lecciones de dermatología, 16ª ed., México, McGraw-Hill, 2015, pp. 56-90.

  14. Reibel F, Cambau E y Aubry A, Update on the epidemiology, diagnosis, and treatment of leprosy, Med Mal Infect 2015; 45(9):383-93. doi: 10.1016/j.medmal.2015.09.002.

  15. Milena Montes A, Orozco B y Gaviria M, Lepra dimorfa en estado reaccional tipo 1 y 2, Rev Asoc Col Dermatol 2009; 17(1):51-3.

  16. Fleta Zaragozano J, Lepra: aspectos clínicos y tratamiento, Med Integral 2001; 38(7):309-14.

  17. Morfín Maciel B y Jiménez Martínez M, Evaluación inmunológica durante el tratamiento de un caso de lepra dimorfa lepromatosa, Rev Alergia Mex 2016; 63(4):413-19. doi: 10.29262/ram.v63i4.170.

  18. Gunawan H, Utami F, Aji Achdiat P, Avriyanti E, Hindritiani R et al., A unique case of borderline lepromatous leprosy with psoriasis-like lesions t all over the body and mycosis fungoides-like lesions on the face, J Clin Tuberc Other Mycobact Dis 2019; 17:100134.

  19. Vora RV, Kota RK y Pariath AK, Leprosy: a mimicker of psoriasis, J Clin Diagn Res 2015; 9(9):1-2.

  20. Re Domínguez ML, Di-Martino Ortiz B y Rodríguez Masi M, Pápulas umbilicadas en un varón adulto joven: ¿cuál es su diagnóstico?, Piel Barc 2017; 32(1):34-9.

  21. Ramos e Silva M y Bessa Rebello PF, Leprosy: recognition and treatment, Am J Clin Dermatol 2001; 2(4):203-11.

  22. Concha RM, Cossío TL, Salazar SI, Fich SF, Pérez CC et al., Enfermedad de Hansen: revisión a propósito de un caso, Rev Chil Infect 2008; 25(1):64-69.

  23. James WD, Elston DM, Treat JR, Rosenbach MA y Neuhaus IM, Hansen disease. En James WD, Elston DM, Treat JR, Rosenbach MA y Neuhaus IM, Andrews’ diseases of the skin: clinical dermatology, 13ª ed., Nueva York, Elsevier, 2019, pp. 336-46.e1.




2020     |     www.medigraphic.com